SILLAJEN BIOTHERAPEUTICS Trademark

Trademark Overview

On Monday, June 23, 2014, a trademark application was filed for SILLAJEN BIOTHERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SILLAJEN BIOTHERAPEUTICS trademark a serial number of 86317022. The federal status of this trademark filing is REGISTERED as of Tuesday, June 19, 2018. This trademark is owned by SillaJen Biotherapeutics, Inc.. The SILLAJEN BIOTHERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing information in the field of research on cancer and biologic pharmaceutical products for the prevention, diagnosis, and treatment of cancer
sillajen biotherapeutics

General Information

Serial Number86317022
Word MarkSILLAJEN BIOTHERAPEUTICS
Filing DateMonday, June 23, 2014
Status700 - REGISTERED
Status DateTuesday, June 19, 2018
Registration Number5498035
Registration DateTuesday, June 19, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 24, 2015

Trademark Statements

Disclaimer with Predetermined Text"BIOTHERAPEUTICS"
Goods and ServicesProviding information in the field of research on cancer and biologic pharmaceutical products for the prevention, diagnosis, and treatment of cancer

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 30, 2014
Primary Code042
First Use Anywhere DateTuesday, April 17, 2018
First Use In Commerce DateTuesday, April 17, 2018

Trademark Owner History

Party NameSillaJen Biotherapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94111
Party NameSillaJen Biotherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94111
Party NameSillaJen Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94111

Trademark Events

Event DateEvent Description
Monday, June 19, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, March 26, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 26, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 26, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 26, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 26, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 19, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, May 17, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, May 16, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 25, 2018STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 18, 2018USE AMENDMENT FILED
Wednesday, April 18, 2018TEAS STATEMENT OF USE RECEIVED
Wednesday, October 25, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 24, 2017SOU EXTENSION 5 GRANTED
Tuesday, October 17, 2017SOU EXTENSION 5 FILED
Tuesday, October 17, 2017TEAS EXTENSION RECEIVED
Saturday, April 22, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 20, 2017SOU EXTENSION 4 GRANTED
Thursday, April 20, 2017SOU EXTENSION 4 FILED
Thursday, April 20, 2017TEAS EXTENSION RECEIVED
Thursday, October 27, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 27, 2016CORRECTED NOA E-MAILED
Wednesday, October 26, 2016SOU EXTENSION 3 GRANTED
Thursday, October 20, 2016SOU EXTENSION 3 FILED
Wednesday, October 26, 2016DIVISIONAL PROCESSING COMPLETE
Thursday, October 20, 2016DIVISIONAL REQUEST RECEIVED
Thursday, October 20, 2016TEAS REQUEST TO DIVIDE RECEIVED
Thursday, October 20, 2016TEAS EXTENSION RECEIVED
Thursday, May 12, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 11, 2016SOU EXTENSION 2 GRANTED
Monday, April 11, 2016SOU EXTENSION 2 FILED
Wednesday, May 11, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 11, 2016TEAS EXTENSION RECEIVED
Tuesday, December 1, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 1, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 22, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 20, 2015SOU EXTENSION 1 GRANTED
Tuesday, October 20, 2015SOU EXTENSION 1 FILED
Tuesday, October 20, 2015TEAS EXTENSION RECEIVED
Tuesday, October 20, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 21, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 24, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 24, 2015PUBLISHED FOR OPPOSITION
Wednesday, February 4, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 21, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 21, 2015ASSIGNED TO LIE
Wednesday, December 31, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 10, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 9, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 9, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 30, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 30, 2014NON-FINAL ACTION E-MAILED
Tuesday, September 30, 2014NON-FINAL ACTION WRITTEN
Monday, September 29, 2014ASSIGNED TO EXAMINER
Monday, June 30, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 26, 2014NEW APPLICATION ENTERED

Related Keywords

biotherapeutics sillajen cancer products prevention diagnosis treatment pharmaceutical biologic information field research